What is the genomic test, and how does it work?

The genomic test is a diagnostic tool that analyzes the activity of 50 genes in tumor tissue to determine the risk of breast cancer returning. The test provides a score that reveals the risk of recurrence, enabling doctors to decide whether chemotherapy is necessary or not.

Who can benefit from the genomic test?

The test is suitable for women with hormone-positive breast cancer, which is the most common form of breast cancer. The test can help identify which patients can safely skip chemotherapy and be treated with hormone therapy alone.

How accurate is the genomic test?

The test has been shown to be highly accurate in predicting the risk of breast cancer recurrence. According to the trial results, the test can identify which patients can safely skip chemotherapy with a high degree of accuracy.

Is the genomic test widely available?

The test is not yet widely available, but it is expected to become more widely available in the coming years. It's essential to talk to your doctor about the test and whether it's right for you.

How much does the genomic test cost?

The cost of the test varies depending on the location and the healthcare system. In the UK, the test is expected to be funded by the NHS, but it's essential to check with your healthcare provider for more information.

What is the genomic test, and how does it work?

The genomic test is a diagnostic tool that analyzes the activity of 50 genes in tumor tissue to determine the risk of breast cancer returning. The test provides a score that reveals the risk of recurrence, enabling doctors to decide whether chemotherapy is necessary or not.

Who can benefit from the genomic test?

The test is suitable for women with hormone-positive breast cancer, which is the most common form of breast cancer. The test can help identify which patients can safely skip chemotherapy and be treated with hormone therapy alone.

How accurate is the genomic test?

The test has been shown to be highly accurate in predicting the risk of breast cancer recurrence. According to the trial results, the test can identify which patients can safely skip chemotherapy with a high degree of accuracy.

Is the genomic test widely available?

The test is not yet widely available, but it is expected to become more widely available in the coming years. It's essential to talk to your doctor about the test and whether it's right for you.

How much does the genomic test cost?

The cost of the test varies depending on the location and the healthcare system. In the UK, the test is expected to be funded by the NHS, but it's essential to check with your healthcare provider for more information.

Back to Trending News

Published: RecentDownload AppJoin Telegram

The Women Caught in the Middle of Breast Cancer

#breast cancer#genomic test#chemotherapy#hormone therapy#personalized medicine#cancer treatment#global

Download App Join Community

ICE Doxing Claims: 0.05% Evidence Rate

30 May 2026Read Article